Bioatla Inc
BCAB
$1.31+3.97%
End of day · as of Oct 4, 2026, 12:16 AM ET
Mkt cap
$5.89M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2023-09-30)
N/A
EPS (H1 2026)
$-3.73
Gross Margin (qtr ended 2023-09-30)
N/A
Profit Margin (qtr ended 2023-09-30)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Use this BCAB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BCAB income, balance, and cash tables.
Bioatla Inc (BCAB) is a biotechnology company in the Healthcare sector.
Latest cached Bioatla Inc (BCAB) net income for Sep 30, 2023 was -$33.3M. Statements: https://lician.com/financials/bcab
Bioatla Inc (BCAB) market capitalization is $5.9M on the latest cached snapshot.
Bioatla Inc (BCAB) cached previous close $1.26; day range $1.23 – $1.65; volume 2,312. Session quote: https://lician.com/quote/bcab
Bioatla Inc (BCAB) latest cached earnings event is "BCAB earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BCAB filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/bcab